Blueprint Medicines Corp
F:2L9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Blueprint Medicines Corp
F:2L9
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2L9's stock price target?
Not Available
2L9 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Blueprint Medicines Corp?
Projected CAGR
34%
The compound annual growth rate for Revenue over the next 3 years is 34%.